
Malcom Mason, MD, Cancer Research Wales Professor of Clinical Oncology at Cardiff University, discusses the significance of the PROTECT study in patients with localized prostate cancer.<br /> ​

Your AI-Trained Oncology Knowledge Connection!


Published: January 18th 2018 | Updated: